AbbVie Inc.ABBVNYSE
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank92
3Y CAGR+119.0%
5Y CAGR+68.1%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+119.0%/yr
Quarterly compound
5Y CAGR
+68.1%/yr
Recent acceleration
Percentile
P92
Near historical high
vs 5Y Ago
13.4x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 205.09% |
| Q3 2025 | -61.10% |
| Q2 2025 | 31.10% |
| Q1 2025 | 350.54% |
| Q4 2024 | -138.89% |
| Q3 2024 | -4.18% |
| Q2 2024 | 42.89% |
| Q1 2024 | -12.43% |
| Q4 2023 | 40.07% |
| Q3 2023 | -49.46% |
| Q2 2023 | 63.04% |
| Q1 2023 | -49.69% |
| Q4 2022 | 19.53% |
| Q3 2022 | 39.70% |
| Q2 2022 | -30.15% |
| Q1 2022 | -7.04% |
| Q4 2021 | 17.84% |
| Q3 2021 | -3.04% |
| Q2 2021 | 8.24% |
| Q1 2021 | 9.33% |
| Q4 2020 | 15.30% |
| Q3 2020 | 332.85% |
| Q2 2020 | -79.13% |
| Q1 2020 | -8.92% |
| Q4 2019 | 51.17% |
| Q3 2019 | -23.03% |
| Q2 2019 | 12.96% |
| Q1 2019 | 223.31% |
| Q4 2018 | -177.27% |
| Q3 2018 | 14.37% |
| Q2 2018 | -4.86% |
| Q1 2018 | 61.82% |
| Q4 2017 | -33.41% |
| Q3 2017 | 1.20% |
| Q2 2017 | 10.59% |
| Q1 2017 | 2.08% |
| Q4 2016 | -0.13% |
| Q3 2016 | -1.09% |
| Q2 2016 | 4.78% |
| Q1 2016 | 7.81% |